407 related articles for article (PubMed ID: 29499317)
1. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
Davis JS; Turnidge J; Tong S
Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
[TBL] [Abstract][Full Text] [Related]
2. Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection.
Schmidt-Hellerau K; Breuninger M; Kessel J; Vehreschild MJGT; Paul G; Reusch J; Jung N; Hellmich M; Fätkenheuer G
Infection; 2024 Jun; 52(3):1159-1163. PubMed ID: 38296936
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
[TBL] [Abstract][Full Text] [Related]
4. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study.
Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D
Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711
[TBL] [Abstract][Full Text] [Related]
5. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Li J; Echevarria KL; Traugott KA
Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
[TBL] [Abstract][Full Text] [Related]
6. Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.
Henderson A; Harris P; Hartel G; Paterson D; Turnidge J; Davis JS; Tong SYC
Int J Antimicrob Agents; 2019 Oct; 54(4):491-495. PubMed ID: 31181352
[TBL] [Abstract][Full Text] [Related]
7. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.
Bidell MR; Patel N; O'Donnell JN
J Antimicrob Chemother; 2018 Oct; 73(10):2643-2651. PubMed ID: 30085140
[TBL] [Abstract][Full Text] [Related]
8. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Loubet P; Burdet C; Vindrios W; Grall N; Wolff M; Yazdanpanah Y; Andremont A; Duval X; Lescure FX
Clin Microbiol Infect; 2018 Feb; 24(2):125-132. PubMed ID: 28698037
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
[TBL] [Abstract][Full Text] [Related]
10. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
Rindone JP; Mellen CK
Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
[TBL] [Abstract][Full Text] [Related]
16. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia.
Weis S; Kesselmeier M; Davis JS; Morris AM; Lee S; Scherag A; Hagel S; Pletz MW
Clin Microbiol Infect; 2019 Jul; 25(7):818-827. PubMed ID: 30928559
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis.
Shi C; Xiao Y; Zhang Q; Li Q; Wang F; Wu J; Lin N
BMC Infect Dis; 2018 Oct; 18(1):508. PubMed ID: 30305037
[TBL] [Abstract][Full Text] [Related]
18. Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
Burrelli CC; Broadbent EK; Margulis A; Snyder GM; Gold HS; McCoy C; Mahoney MV; Hirsch EB
Chemotherapy; 2018; 63(6):345-351. PubMed ID: 30965335
[TBL] [Abstract][Full Text] [Related]
19. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
[TBL] [Abstract][Full Text] [Related]
20. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.
Lefèvre B; Hoen B; Goehringer F; Sime WN; Aissa N; Alauzet C; Jeanmaire E; Hénard S; Filippetti L; Selton-Suty C; Agrinier N;
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2605-2616. PubMed ID: 34383175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]